Sponsor Pipeline

Anbogen Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05532696 Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients Advanced Solid Tumor Recruiting
NCT07244705 A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced… Colorectal Cancer (Diagnosis) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1)
Get alerts when Anbogen Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free